Clinical Site
Dublin D04 T6F4
0 studies enrolling now · 3 studies all time
What they study most
C3 Glomerulopathy (C3G), Hidradenitis Suppurativa
Studies at this site
- Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
- Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
- Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa — Completed